Ready, set, slow down
The first new TB drugs in decades are approved for use, but remain largely out of the reach of patients. Why is this and how can we speed up access to these new lifesaving treatments?
Photo by Aris Messinis
Photo by Juan Carlos Tomasi
Tell the U.S.: Stop bullying India, pharmacy of the developing world!
Join us in urging Prime Minister Modi and President Obama to protect lives over corporate interests!
NEW MSF REPORT
The 2nd edition of The Right Shot is one of the most comprehensive publications on comparative vaccines prices to date, bringing together in one place information on 16 key vaccines across 13 countries.
TAKE ACTION TO FIX THE TPP
The recent leak of theTrans-Pacific Partnership trade agreement negotiation text confirms our worst fears that access to affordable medicines is in grave danger. Ask the US Government to stop it's attack to affordable medicines »
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.
Stories from the Field
- » The Luxury of MDR-TB treatment in Myanmar: An impossible choice for many
- » South Sudan: Fighting a measles outbreak in Yida refugee camp
- » Ethiopia: Tens of thousands of South Sudanese refugees receive cholera vaccine
- » MSF team vaccinated 38,000 children against measles in the Democratic Republic of Congo